TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
PBLS

Parabilis Medicines, Inc.

Healthcare · Biotechnology

30.30$ -0.5% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow PBLS
Line item Q1 25 Q2 25 Q1 26 Q2 26
– – – –
– -5.5% -1.9% -2.1%
– -3.4% +58.4% +178.7%
– -131.6% – –
– -78.4% +2,206.3% +66.9%
– +266.4% -101.5% +9,131.2%
– +2.9% +2,611.1% +0.1%
– -100.2% – +126.8%
– -116.9% – +151.6%
– – – –

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?